Cytarabine 71288-0109-20

Package NDC

71288-0109-20

Manufacturer: Meitheal Pharmaceuticals Inc.
Dosage Form: Injection, Solution
Route: Intrathecal, Intravenous, And Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: July 17, 2018
Listing Expires: December 31, 2026
Application: ANDA205696

Need to source Cytarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Cytarabine	2 g/20mL

Drug Class

Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]

Selected Package

71288-0109-20Selected

1 VIAL, SINGLE-DOSE in 1 CARTON (71288-109-20) / 20 mL in 1 VIAL, SINGLE-DOSE